CFSIX
Price
$20.81
Change
-$0.03 (-0.14%)
Updated
Dec 3 closing price
Net Assets
2.34B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

CFSIX vs VIGRX

Header iconCFSIX vs VIGRX Comparison
Open Charts CFSIX vs VIGRXBanner chart's image
Touchstone Sands Capital Select Growth Y
Price$20.81
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets2.34B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
CFSIX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
CFSIX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFSIX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. CFSIX (2.34B). VIGRX pays higher dividends than CFSIX: VIGRX (0.30) vs CFSIX (0.00). CFSIX was incepted earlier than VIGRX: CFSIX (21 years) vs VIGRX (33 years). CFSIX (0.88) is less costly to investors than VIGRX (0.17). CFSIX is a more actively managed with annual turnover of: 41.00 vs. VIGRX (11.00). CFSIX has a lower initial minimum investment than VIGRX: CFSIX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. CFSIX (11.11). VIGRX return over 5 years is better than : 99.11 vs. CFSIX (-2.89).
CFSIXVIGRXCFSIX / VIGRX
Total Expense Ratio0.870.17512%
Annual Report Gross Expense Ratio0.880.17518%
Fund Existence21 years33 years-
Gain YTD16.25719.76482%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B357B1%
Annual Yield % from dividends0.000.30-
Returns for 1 year11.1118.4960%
Returns for 3 years103.22110.8293%
Returns for 5 years-2.8999.11-3%
Returns for 10 years9.53349.133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT